Newsroom
Synapse CEO announcement
Synapse Electroceutical today announced that the Board of Directors has appointed Andy Boyes as Interim Chief Executive Officer. John Gildersleeve will assume the role of Business Development Director and will continue to serve as an executive director on the Board.
Read this article
Andy Boyes appointed as Non-Executive Director to Synapse Electroceutical Limited
Synapse Electroceutical Limited is delighted to announce the appointment of Andy Boyes to the Board. Andy has enjoyed a successful, 32 year career at Smith & Nephew, the FTSE 100 medical technology business engaged in developing, manufacturing, marketing and selling medical devices in the Advanced Wound Management and Advanced Surgical Devices sectors with sales in excess of £4 billion. Andy is passionate
about the wound care sector and helping improve the lives of patients suffering with debilitating complex wounds and since leaving Smith & Nephew has focussed on providing Board level support and strategic direction in the sector.
'Electrical stimulation therapy and electroceutical treatment for the management of venous leg ulcers’ published in Community Wound Care
The use of innovative technologies for transforming and improving clinical outcomes and reducing costs in the NHS was an integral component of the NHS Five Year Forward View (2014). The use of electroceutical treatment has been demonstrated to both improve patient outcomes and reduce costs to the NHS for the management of chronic wounds.
Read this articleOther articles
- ‘The health economic burden that acute and chronic wounds impose on an average clinical commissioning group / health board in the UK’ published in the Journal of Wound Care
- ‘Health economic burden that different wound types impose on the UK’s National Health Service’ published in the International Wound Journal
- 'Using electroceutical treatment to reduce symptoms and improve healing in chronic wounds’ published in Primary Health Care
- 'Breaking the cycle of hard-to-heal wounds with electroceutical treatment’ presentation to the Leg Ulcers: Right Care, Right Time Wounds UK Nurse Symposium
- 'Venous leg ulcer management in clinical practice in the UK: costs and outcomes’ published in the International Wound Journal
- 'Right Care, Right Time - An evaluation using an electroceutical treatment to determine the clinical outcomes in a large NHS Trust’ poster presented at Wounds UK
- Synapse Electroceutical Limited supports Bromley Healthcare Charity
- TVNI Meeting 2017
- Best Practice Event 2016
- Accel‑Heal® on BBC News
- Accel‑Heal® offers a potential saving of £495 million to the NHS
- Japanese Patent and Australia and New Zealand Trademarks for Accel‑Heal®
- Living with a leg ulcer
You can view our news stories by category
